Back
BioCryst Pharmaceuticals, Inc. Stock Price Chart
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
63
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$7.84
Seasonality Move:
8.4%
7 Day Trial
ALL ACCESS PASS
$
7
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BCRX is experiencing selling pressure, which indicates risk of future bearish movement.
BioCryst Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.24 | Buy |
| 20-day SMA: | 7.13 | Buy |
| 50-day SMA: | 7.14 | Buy |
| 200-day SMA: | 8.31 | Sell |
| 8-day EMA: | 7.38 | Buy |
| 20-day EMA: | 7.21 | Buy |
| 50-day EMA: | 7.3 | Buy |
| 200-day EMA: | 7.91 | Sell |
BioCryst Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.09 | Buy |
| Relative Strength Index (14 RSI): | 67.18 | Buy |
| Chaikin Money Flow: | -5309139 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.86 - 7.38) | Buy |
| Bollinger Bands (100): | (7.07 - 8.33) | Buy |
BioCryst Pharmaceuticals, Inc. Technical Analysis
| Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioCryst Pharmaceuticals, Inc. Stock
Is BioCryst Pharmaceuticals, Inc. Stock a Buy?
-
BioCryst Pharmaceuticals, Inc. share price is 7.83 while BCRX 8-day simple moving average is 7.24, which is a Buy signal.
-
The stock price of BCRX is 7.83 while BioCryst Pharmaceuticals, Inc. 20-day SMA is 7.13, which makes it a Buy.
-
BioCryst Pharmaceuticals, Inc. 50-day simple moving average is 7.14 while BCRX share price is 7.83, making it a Buy technically.
-
BCRX stock price is 7.83 and BioCryst Pharmaceuticals, Inc. 200-day simple moving average is 8.31, creating a Sell signal.
BCRX Technical Analysis vs Fundamental Analysis
Buy
63
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
Is BioCryst Pharmaceuticals, Inc. a Buy or a Sell?
-
BioCryst Pharmaceuticals, Inc. stock is rated a BuyThe current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $7.83. The Score for BCRX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
BioCryst Pharmaceuticals, Inc. Stock Info
Market Cap:
1.6B
Price in USD:
7.83
Share Volume:
6.7M
BioCryst Pharmaceuticals, Inc. 52-Week Range
52-Week High:
11.31
52-Week Low:
6.00
Buy
63
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
BioCryst Pharmaceuticals, Inc. Share Price Forecast
-
What is the BioCryst Pharmaceuticals, Inc. stock price today?The BioCryst Pharmaceuticals, Inc. stock price is 7.83 USD today.
-
Will BCRX stock go up or go down?BioCryst Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BioCryst Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioCryst Pharmaceuticals, Inc. is not overvalued.
Is BioCryst Pharmaceuticals, Inc. Stock a Buy?
-
BioCryst Pharmaceuticals, Inc. share price is 7.83 while BCRX 8-day exponential moving average is 7.38, which is a Buy signal.
-
The stock price of BCRX is 7.83 while BioCryst Pharmaceuticals, Inc. 20-day EMA is 7.21, which makes it a Buy.
-
BioCryst Pharmaceuticals, Inc. 50-day exponential moving average is 7.30 while BCRX share price is 7.83, making it a Buy technically.
-
BCRX stock price is 7.83 and BioCryst Pharmaceuticals, Inc. 200-day simple moving average is 7.91, creating a Sell signal.
Fundamental Analysis of BioCryst Pharmaceuticals, Inc.
Is BioCryst Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and a decrease next year of $0.04 per share.
Technical Analysis of BioCryst Pharmaceuticals, Inc.
Should I short BioCryst Pharmaceuticals, Inc. stock?
-
BCRX Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting BioCryst Pharmaceuticals, Inc. is a Buy
-
BioCryst Pharmaceuticals, Inc. Relative Strength Index (RSI) is 67.18, which suggest BioCryst Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for BioCryst Pharmaceuticals, Inc. is (6.86 - 7.38), which suggest BioCryst Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for BioCryst Pharmaceuticals, Inc. is (7.07 - 8.33), which suggest BioCryst Pharmaceuticals, Inc. is a Buy
* BioCryst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.